Apollo Hospitals Enterprise Limited Stock Price Today (NSE: APOLLOHOSP)
Fundamental Score
Apollo Hospitals Enterprise Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Apollo Hospitals Enterprise Limited share price today is ₹8817.00, down 1.16% on NSE/BSE as of 21 August 2026. Apollo Hospitals Enterprise Limited (APOLLOHOSP) is a Large-cap company in the Hospital sector with a market capitalisation of ₹1.28L (Cr). The 52-week high for APOLLOHOSP share price is ₹9050.00 and the 52-week low is ₹6696.50. At a P/E ratio of 65.68x, APOLLOHOSP is currently trading above its industry average P/E of 48.79x. The company has a Return on Equity (ROE) of 22.11% and a debt-to-equity ratio of 0.90.
Apollo Hospitals Enterprise Limited Share Price Chart — NSE/BSE Historical Performance
Apollo Hospitals Enterprise Limited share price chart: 4.41% return over the past month. 52-week high ₹9050.00, 52-week low ₹6696.50.
Apollo Hospitals Enterprise Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹8825.50 | ₹8907.00 | ₹8786.50 | ₹8817.00 | 4.75L (Cr) | |
| ₹8615.00 | ₹8925.00 | ₹8588.50 | ₹8920.50 | 12.76L (Cr) | |
| ₹8740.50 | ₹8786.00 | ₹8554.00 | ₹8600.00 | 7.97L (Cr) | |
| ₹8750.50 | ₹8775.50 | ₹8507.50 | ₹8597.00 | 8.77L (Cr) | |
| ₹8982.00 | ₹8990.00 | ₹8672.50 | ₹8750.50 | 5.62L (Cr) | |
| ₹8945.00 | ₹8971.00 | ₹8865.50 | ₹8912.00 | 4.12L (Cr) | |
| ₹9000.00 | ₹9000.00 | ₹8922.00 | ₹8945.00 | 2.74L (Cr) | |
| ₹8947.00 | ₹9015.00 | ₹8880.00 | ₹8974.50 | 4.00L (Cr) | |
| ₹9009.00 | ₹9009.00 | ₹8820.00 | ₹8910.00 | 2.89L (Cr) | |
| ₹8800.00 | ₹9050.00 | ₹8760.00 | ₹9050.00 | 2.59L (Cr) |
Apollo Hospitals Enterprise Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹9030.00 | ₹9050.00 | ₹8507.50 | ₹8817.00 | -2.36% | |
| ₹8681.00 | ₹9036.50 | ₹8611.50 | ₹8957.00 | +3.18% | |
| ₹8221.50 | ₹8770.00 | ₹7816.00 | ₹8682.00 | +5.60% | |
| ₹7699.50 | ₹8443.00 | ₹7673.00 | ₹8176.50 | +6.20% | |
| ₹7549.00 | ₹7878.50 | ₹7150.50 | ₹7636.50 | +1.16% | |
| ₹7621.00 | ₹7870.00 | ₹7080.00 | ₹7419.00 | -2.65% | |
| ₹6915.00 | ₹7870.50 | ₹6831.00 | ₹7821.50 | +13.11% | |
| ₹7063.00 | ₹7488.00 | ₹6696.50 | ₹6960.50 | -1.45% | |
| ₹7375.00 | ₹7381.50 | ₹6881.00 | ₹7042.50 | -4.51% | |
| ₹7675.00 | ₹7891.00 | ₹7300.00 | ₹7335.50 | -4.42% | |
| ₹7409.50 | ₹8099.50 | ₹7359.00 | ₹7681.00 | +3.66% | |
| ₹7595.50 | ₹7956.00 | ₹7400.00 | ₹7409.00 | -2.46% |
AI Research Briefing
Powered by Gemini · 2026-04-22
Apollo is a growth story trading at a premium; execution is everything.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Apollo Hospitals reported a 35% YoY increase in Q3 net profit, reaching , with revenue up 17% to The board declared an interim dividend of Apollo received NCLT approval for a composite scheme involving Apollo HealthCo, Keimed, and Apollo Healthtech, with stakeholder meetings scheduled in May 2026. Apollo is also expanding, establishing a multi-specialty hospital in Dwarka, New Delhi, on 9.33 acres leased for 55 years, with an annual license fee of s starting in the fifth year. Apollo completed the acquisition of the remaining stake in Apollo Health and Lifestyle Limited (AHLL) for , gaining 100% ownership.
CORE STORY (THE REAL GAME)
Apollo is a bet on the long-term growth of private healthcare in India, driven by increasing affordability, rising medical tourism, and consolidation in the hospital and pharmacy distribution sectors. They are trying to become a vertically integrated healthcare giant.
- Strong Q3 results with 35% YoY profit growth
- NCLT approval for restructuring unlocks potential synergies
- Expansion into Dwarka signals continued growth ambition
- Faster-than-expected integration of acquired entities
- Positive regulatory changes favoring private healthcare
- Successful execution of the digital health strategy
- High valuation relative to industry peers
- Promoter pledging indicates potential financial strain
- Government regulation on hospital billing could impact revenue
FII holdings increased slightly (Δ 0.71%), while DII holdings decreased (Δ -0.22%), indicating mixed institutional sentiment.
Rising medical costs and increased government scrutiny create both opportunities and headwinds for the healthcare sector.
Apollo is establishing a new multi-specialty hospital in Dwarka, New Delhi, on 9.33 acres leased for 55 years.
Yes, Free Cash Flow 5Y is ₹3504.8 Cr.
Apollo's future hinges on successful execution of its expansion and restructuring plans. Sustained earnings growth is crucial to justify its premium valuation.
Primary Thesis Risk
Valuation compression if growth slows.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Apollo Hospitals Enterprise Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Apollo Hospitals Enterprise Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of APOLLOHOSP across key market metrics for learning purposes.
Positive Indicators
11 factors identified
Strong Return on Equity (22.11%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (17.89%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Robust Profit Growth (35.86%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (18.12%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (19.03% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (77.79% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (77.79% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Strong Interest Coverage (6.96x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Healthy Liquidity Position (Current Ratio: 1.54)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Strong Cash Generation (₹3445.40 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Strong Institutional Confidence (FII+DII: 65.21%)
Observation: Significant professional investor participation.
Analysis: High institutional holding often signals thorough due diligence.
Risk Factors
3 factors identified
Premium Valuation Risk (P/E: 65.68x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
High Price-to-Book Ratio (15.44x)
Observation: Trading at significant premium to book value.
Analysis: High P/B ratios may indicate overvaluation relative to asset base.
Low Promoter Commitment (28.02%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
Apollo Hospitals Enterprise Limited vs Hospital Peers
Peer Comparison - Hospital
Compare Apollo Hospitals Enterprise Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Apollo Hospitals Enterprise LimitedApollo Hospital...Selected✓ APOLLOHOSP • 508869 | 62.1/100 | ₹8817.00₹8817 | ₹128448.55₹128448.55 | 65.68Average 65.7 Average | 22.11%Excellent 22.11% Excellent | 17.89%Good 17.89% Good | 0.90Good 0.9 Good | 77.79%Excellent 77.79% Excellent | 19.03%Excellent 19.03% Excellent | 0.22% |
Dr Agarwals Health Care LtdDr Agarwals Hea... AGARWALEYE • 544350 | 48.5/100 | ₹480.05₹480 | ₹15618.15₹15618.15 | 117.89Average 117.9 Average | 6.81%Poor 6.81% Poor | 11.12%Average 11.12% Average | 0.53Good 0.5 Good | 34.42%Excellent 34.42% Excellent | 34.58%Excellent 34.58% Excellent | 0.00% |
Yatharth Hospital & Trauma Care Services LtdYatharth Hospit... YATHARTH • 543950 | 53/100 | ₹812.95₹813 | ₹8100.43₹8100.43 | 46.19Average 46.2 Average | 10.36%Average 10.36% Average | 12.37%Average 12.37% Average | 0.15Excellent 0.1 Excellent | 57.39%Excellent 57.39% Excellent | 41.18%Excellent 41.18% Excellent | 0.00% |
Artemis Medicare Services LtdArtemis Medicar... ARTEMISMED • 542919 | 69.5/100 | ₹273.45₹273 | ₹4376.46₹4376.46 | 41.39Average 41.4 Average | 11.88%Average 11.88% Average | 14.53%Average 14.53% Average | 0.28Excellent 0.3 Excellent | 75.56%Excellent 75.56% Excellent | 21.41%Excellent 21.41% Excellent | 0.16% |
Unihealth Hospitals LtdUnihealth Hospi... UNIHEALTH • | 65.8/100 | ₹717.00₹717 | ₹1123.65₹1123.65 | 43.83Average 43.8 Average | 21.46%Excellent 21.46% Excellent | 24.48%Excellent 24.48% Excellent | 0.24Excellent 0.2 Excellent | 38.61%Excellent 38.61% Excellent | 38.17%Excellent 38.17% Excellent | 0.00% |
Aashka Hospitals LtdAashka Hospital... AASHKA • 543346 | 36.5/100 | ₹73.00₹73 | ₹191.65₹191.65 | 67.48Average 67.5 Average | 2.80%Poor 2.80% Poor | 4.05%Poor 4.05% Poor | 0.08Excellent 0.1 Excellent | -7.13%Poor -7.13% Poor | -10.78%Poor -10.78% Poor | 0.00% |
Abateas Industries LtdAbateas Industr... ABATEAS • 531658 | 34.4/100 | ₹9.71₹10 | ₹155.55₹155.55 | 12.65Average 12.7 Average | 7.30%Poor 7.30% Poor | 6.70%Poor 6.70% Poor | 0.06Excellent 0.1 Excellent | — — | — — | 0.00% |
Nephro Care India LimitedNephro Care Ind... NEPHROCARE • | 45.4/100 | ₹65.40₹65 | ₹108.73₹108.73 | 32.26Average 32.3 Average | 6.11%Poor 6.11% Poor | 8.70%Poor 8.70% Poor | 0.00Excellent 0.0 Excellent | 106.38%Excellent 106.38% Excellent | 117.57%Excellent 117.57% Excellent | 0.00% |
MAITREYA MEDICAREMAITREYA MEDICA... MAITREYA • | 6.9/100 | ₹132.60₹133 | ₹83.34₹83.34 | — — | -8.86%Poor -8.86% Poor | -2.18%Poor -2.18% Poor | 0.80Good 0.8 Good | — — | -4.32%Poor -4.32% Poor | 0.00% |
SANGANI HOSPITALSSANGANI HOSPITA... SANGANI • | 53.4/100 | ₹42.70₹43 | ₹61.86₹61.86 | 20.69Average 20.7 Average | 7.76%Poor 7.76% Poor | 17.37%Good 17.37% Good | 0.04Excellent 0.0 Excellent | — — | — — | 0.00% |
31/100 | ₹17.75₹18 | ₹43.73₹43.73 | 61.59Average 61.6 Average | 1.41%Poor 1.41% Poor | 3.56%Poor 3.56% Poor | 0.41Excellent 0.4 Excellent | -29.65%Poor -29.65% Poor | 9.44%Good 9.44% Good | 0.00% | |
Top Hospital Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
Apollo Hospitals Enterprise Limited PE Ratio History
Historical price-to-earnings ratio for APOLLOHOSP — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹100.56 | ₹7042.50 | 70x |
| FY 2024 | ₹62.50 | ₹7296.35 | 116.7x |
| FY 2023 | ₹56.97 | ₹5704.10 | 100.1x |
| FY 2022 | ₹73.42 | ₹4477.60 | 61x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Apollo Hospitals Enterprise Limited Dividend History
Annual cash dividends paid by APOLLOHOSP — dividend yield 0.22%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹273.20 Cr |
| FY 2024 | ₹215.70 Cr |
| FY 2023 | ₹255.20 Cr |
| FY 2022 | ₹43.30 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Apollo Hospitals Enterprise Limited Quarterly Performance
Latest quarterly metrics for APOLLOHOSP — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
18.12%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
35.86%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
19.03%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
77.79%
Compounded annual net profit growth over 5 years
Apollo Hospitals Enterprise Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for APOLLOHOSP — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Apollo Hospitals Enterprise Limited Financial Statements
Annual income statement, balance sheet and cash flow for Apollo Hospitals Enterprise Limited (APOLLOHOSP) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Apollo Hospitals Enterprise Limited
About APOLLOHOSP (Apollo Hospitals Enterprise Limited)
Apollo Hospitals Enterprise Ltd is a beacon of advanced medical care, standing as a prominent institution within the Indian healthcare landscape. Its sprawling network encompasses ...a multitude of hospitals, each meticulously designed and equipped to address a wide spectrum of health needs. From routine check-ups to complex surgical procedures, Apollo Hospitals embodies a commitment to comprehensive patient care. Stepping into an Apollo facility, one is immediately struck by the seamless blend of cutting-edge technology and compassionate human interaction. Highly skilled medical professionals, supported by state-of-the-art diagnostic tools, work tirelessly to provide accurate diagnoses and effective treatment plans. The environment is not merely clinical; it is carefully curated to promote healing and well-being, with comfortable waiting areas, serene patient rooms, and a focus on creating a supportive atmosphere for both patients and their families. The strength of Apollo Hospitals lies not only in its physical infrastructure but also in its diverse range of medical specialties. It serves as a hub for groundbreaking research and innovation, constantly pushing the boundaries of medical knowledge and practice. Its centers of excellence are renowned for their expertise in critical areas such as cardiology, oncology, and neurology, attracting patients from across the country and beyond. Apollo's dedication to medical advancement is reflected in its adoption of minimally invasive surgical techniques, robotic surgery, and other cutting-edge technologies. By embracing these advancements, Apollo Hospitals ensures that patients have access to the most effective and least disruptive treatment options available. The focus on specialization and innovation allows Apollo to provide the most specialized medical treatment to its patients. Beyond its hospitals, Apollo Hospitals Enterprise Ltd extends its reach through a network of pharmacies and diagnostic centers, making healthcare more accessible to a wider population. This integrated approach, combining hospital care with outpatient services, ensures continuity of care and promotes preventative healthcare practices. Apollo is committed to empowering individuals to take control of their health through education, wellness programs, and convenient access to essential medications and diagnostic testing. By fostering a culture of proactive health management, Apollo Hospitals strives to improve the overall health and well-being of the communities it serves.
Company Details
Key Leadership
Corporate Events
Latest News
APOLLOHOSP Share Price: Frequently Asked Questions
What is the current share price of Apollo Hospitals Enterprise Limited?
Apollo Hospitals Enterprise Limited (APOLLOHOSP) trades at ₹8817.00 on NSE and BSE. Market cap ₹1.28L (Cr). Educational data only.
What is the P/E ratio of Apollo Hospitals Enterprise Limited?
Apollo Hospitals Enterprise Limited has a P/E of 65.68x vs industry average 48.79x.
What is the Bull Run score for Apollo Hospitals Enterprise Limited?
Apollo Hospitals Enterprise Limited has a Bull Run score of 62.1/100 based on 25+ financial parameters.
Does Apollo Hospitals Enterprise Limited pay dividends?
Apollo Hospitals Enterprise Limited has a dividend yield of 0.22%. Past dividends don't guarantee future payments.
What is the ROE of Apollo Hospitals Enterprise Limited?
Apollo Hospitals Enterprise Limited has ROE of 22.11%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Apollo Hospitals Enterprise Limited?
Apollo Hospitals Enterprise Limited has debt-to-equity of 0.90.
Is Apollo Hospitals Enterprise Limited a good investment?
Bull Run gives Apollo Hospitals Enterprise Limited a score of 62.1/100. This is not investment advice — consult a SEBI-registered advisor.